← Company intelligence

Robot maker · registered

Momentis Surgical

Corporate marketmedicalCurated record

Anovo single-port surgical robotic platform features miniature humanoid-shaped arms with 360° multi-planar articulation across shoulder, elbow, and wrist joints; second-generation platform (FDA-cleared Nov 2024) adds haptic force feedback and dual-mode articulation (retroflexion and anteflexion), enabling the world's first FDA-cleared robotic system operable in both modes through a single port.

HeadquartersOr Yehuda, IL
Founded2013
Corporate funding$128M
Team51-200
Deployments4
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries D
FoundersDvir Cohen (CEO, co-founder), Nir Shvalb (co-founder)
Regions servedNorth America, Europe
Countries deployedUS, BE
Service footprintHQ Tel Aviv, Israel; US subsidiary Fort Lauderdale FL; Anovo commercially deployed in US (FL, TX) and Belgium; Momentis University surgeon training platform
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Anovo Gen 2

  • 360-degree articulation across shoulder, elbow, and wrist joints of miniature humanoid robotic arms

    vendor-stated multi-planar articulation range of Anovo robotic arms

    Claim source
  • Haptic force feedback; first FDA-cleared single-port robotic system with this capability

    vendor-stated tactile feedback to surgeon console

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2024-11-11Kendall Regional Medical Centersurgical hospitalUSNot disclosedAnnouncement
2024-10-15Imelda Hospital (Bonheiden, Belgium)surgical hospitalBENot disclosedAnnouncement
2022-11-01Medical City PlanohospitalUSNot disclosedAnnouncement
2022-10-01HCA Oviedo Medical CenterhospitalUSNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordPeregrine VenturesCerosOurCrowdAccelmedLIP VenturesJibe Ventures
TL

Company timeline

Milestones and announcements

2024-11-01FDA 510(k) clearance for second-generation Anovo platform with haptic feedback and dual-mode articulation (retroflexion and anteflexion)PRNewswire
2024-10-15FDA 510(k) clearance for Anovo in ventral hernia repair: first single-port robotic clearance for general surgery in the USPRNewswire
2023-11-16Raised Series D extension round to continue Anovo commercializationTracxn
2022-07-05Rebranded from Memic Innovative Surgery to Momentis Surgical; product renamed from Hominis to AnovoPRNewswire
2021-11-01Raised $96M Series D led by Peregrine VenturesTracxn
SC

Source ledger

7 unique public sources